---
figid: PMC8366090__CAM4-10-5405-g001
figtitle: Fragility of randomized trials supporting cancer drug approvals stratified
  by approval pathway and review designations
organisms:
- Homo sapiens
organisms_ner:
- Drosophila melanogaster
pmcid: PMC8366090
filename: CAM4-10-5405-g001.jpg
figlink: /pmc/articles/PMC8366090/figure/cam44029-fig-0001/
number: F1
caption: Schema for study inclusion. KM‐Kaplan‐Meier; PFS‐progression free survival;
  OS‐overall survival; RFS‐relapse free survival; DFS‐disease free survival; MFS‐metastasis
  free survival; TTP‐time to progression; ORR‐objective response rate; pCR‐pathological
  complete response
papertitle: Fragility of randomized trials supporting cancer drug approvals stratified
  by approval pathway and review designations.
reftext: Brooke E. Wilson, et al. Cancer Med. 2021 Aug;10(16):5405-5414.
year: '2021'
doi: 10.1002/cam4.4029
journal_title: Cancer Medicine
journal_nlm_ta: Cancer Med
publisher_name: John Wiley and Sons Inc.
keywords: accelerated approvals | FDA approvals | fragility index | trial robustness
automl_pathway: 0.8508728
figid_alias: PMC8366090__F1
figtype: Figure
redirect_from: /figures/PMC8366090__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8366090__CAM4-10-5405-g001.html
  '@type': Dataset
  description: Schema for study inclusion. KM‐Kaplan‐Meier; PFS‐progression free survival;
    OS‐overall survival; RFS‐relapse free survival; DFS‐disease free survival; MFS‐metastasis
    free survival; TTP‐time to progression; ORR‐objective response rate; pCR‐pathological
    complete response
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mocs1
  - 'On'
  - crn
  - fl
  - fi
  - fit
  - cnn
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - ttp
  - Fs
  - l(1)N15
---
